Skip to main content
Sheela Foam Limited logo

Sheela Foam Limited — Investor Relations & Filings

Ticker · SFL ISIN · INE916U01025 LEI · 3358009OJCM3IHW2T747 BSE.NS Manufacturing
Filings indexed 1,173 across all filing types
Latest filing 2026-06-08 Regulatory Filings
Country IN India
Listing BSE.NS SFL

About Sheela Foam Limited

https://www.sheelafoam.com

Sheela Foam Limited is a leading manufacturer of polyurethane (PU) foam and comfort products. The company operates a diverse portfolio, most notably through its flagship brand, Sleepwell, which provides mattresses, pillows, and cushioning materials. Its technical foam division supplies specialized products for the automotive, acoustic, and industrial sectors, including flame-retardant and reticulated foams. With a robust manufacturing infrastructure and a significant international presence through subsidiaries in Australia and Europe, the company focuses on research-driven product development and advanced foam technologies. Its operations encompass a wide distribution network and integrated supply chain, catering to both retail consumers and original equipment manufacturers (OEMs) across global markets.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is an SEBI Regulation 30 disclosure to stock exchanges notifying the schedule of a one-on-one virtual meeting with an investor. It does not contain financial statements, report contents, earnings data, or presentations. It is a compliance announcement under listing obligations. This fits a general regulatory announcement category, so it should be classified as Regulatory Filings (RNS).
2026-06-08 English
Investor Meet on June 11, 2026
Regulatory Filings Classification · 95% confidence The document is a formal SEBI Listing Obligations disclosure notifying stock exchanges of the schedule for a one‐on‐one virtual investor/analyst meeting. It contains no financial data, earnings, presentations, or substantive report contents—only an operational intimation under Regulation 30 of SEBI LODR. Therefore, it is a general regulatory announcement and falls under the fallback category Regulatory Filings (RNS).
2026-06-08 English
Completion of Independent Directors
Board/Management Information Classification · 89% confidence The document is a notification under Regulation 30 of the SEBI Listing Regulations informing stock exchanges of the cessation of three Non‐Executive Independent Directors upon completion of their second terms. It details changes in the board composition and provides annexed particulars of each director’s cessation. This is clearly an announcement of changes in the company’s board of directors, fitting the Board/Management Information category.
2026-06-06 English
Change in Management
Board/Management Information Classification · 88% confidence The document is a formal regulatory announcement under SEBI Listing Regulations disclosing the cessation of three Non-Executive Independent Directors upon completion of their terms. This clearly constitutes an announcement of changes in the company's board of directors, matching the definition for Board/Management Information (Code: MANG).
2026-06-06 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings Classification · 50% confidence The document is a short regulatory disclosure under SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 (Regulation 31(4)) stating that the promoters have not created any encumbrance on their shares during the financial year. It is a compliance announcement to stock exchanges and does not contain financial statements, management discussion, or other substantive report content. This fits the catch-all category “Regulatory Filings” (RNS).
2026-06-05 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 92% confidence The document is an intimation under SEBI (Listing Obligations & Disclosure Requirements) Regulations regarding the schedule of an investor/analyst meeting. It is a regulatory disclosure notice rather than a financial report, earnings release, or management presentation. It does not contain financial statements or detailed operational data, nor is it announcing publication of a report. Therefore, it falls under a general regulatory announcement, categorized as Regulatory Filings (RNS).
2026-05-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.